Fatty Acids and Attention Deficit and Hyperactivity Disorder Symptoms

This study aimed to evaluate the longitudinal association between n-6:n-3 LCPUFAs ratio in cord blood and child ADHD symptoms at 4 and 7 years old. This study was based on the INMA project, a population-based birth cohort in Spain. Higher cord blood n-6:n-3 ratio was associated with higher subclinical ADHD symptoms during early and mid-childhood.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Child Behavior Problem Attention Deficit Disorder with Hyperactivity Attention Deficit Hyperactivity Disorder Attention Deficit and Disruptive Behavior Disorders Fatty Acid Deficiency Mental Disorders Neurodevelopmental Disorders

Age range

4 year–8 year

Sex eligibility

All sexes

Study type

Observational

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Age 16 years or older
Singleton pregnancy
No use of assisted reproductive techniques
Intention to deliver at the reference hospital
Ability to speak and understand Spanish or a local language

Treatment and study plan

Primary outcomes

Fatty acid ratio in cord blood

Time frame: 2004-2008
ADHD 4 years old

Time frame: 2008-2012
ADHD 7 years old

Time frame: 2012-2016

Sponsors and collaborators

Lead sponsor

Barcelona Institute for Global Health

Other

Registry information

Official study title

Prenatal Omega-6/Omega-3 Ratio and Attention Deficit and Hyperactivity Disorder Symptoms in Children: a Population-based Longitudinal Study

Important dates

Study start: 2003
Primary completion: 2015
Study completion: 2015
First posted: Sep 14, 2017
Registry last updated: Jun 18, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed